Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120064483 | 12006448 | 3 | F | 20160130 | 20160908 | 20160204 | 20160919 | PER | PHEH2016US002758 | NOVARTIS | 64.17 | YR | F | Y | 0.00000 | 20160919 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120064483 | 12006448 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | U | UNKNOWN | 21588 | 400 | MG | TABLET | QD | ||||
| 120064483 | 12006448 | 2 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 120064483 | 12006448 | 3 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120064483 | 12006448 | 1 | Gastrointestinal stromal tumour |
| 120064483 | 12006448 | 2 | Hypertension |
| 120064483 | 12006448 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120064483 | 12006448 | Cough | |
| 120064483 | 12006448 | Eczema | |
| 120064483 | 12006448 | Rash | |
| 120064483 | 12006448 | Sinusitis | |
| 120064483 | 12006448 | Tooth loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |